CTTH OTC
CTT Pharmaceutical Holdings, Inc.
1W: +1.9%
1M: +12.5%
3M: -23.6%
YTD: -9.0%
1Y: -5.0%
3Y: +436.6%
5Y: -27.5%
$0.06
-0.00 (-3.51%)
Weekly Expected Move ±11.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.3M
52W Range0.035-0.1
Volume33,714
Avg Volume29,706
Beta0.72
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORyan Khouri
Employees1
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date1997-04-18
Websitecttpharmaceuticals.com
3853 Northdale Blvd
Tampa, FL 33624
US
Tampa, FL 33624
US
613-241-9959
About CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The companyâs technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Latest News
[S-1/A] CTT PHARMACEUTICAL HOLDINGS, INC. Amends IPO Registration Statement - Stock Titan
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
CTT Pharma's CEO will issue a Letter to Shareholders
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| CTT PHARMACEUTICAL H | P-Purchase | 3,400 | $0.06 | 2026-09-28 |
| CTT PHARMACEUTICAL H | P-Purchase | 10,100 | $0.04 | 2026-09-22 |
| CTT PHARMACEUTICAL H | P-Purchase | 10,100 | $0.04 | 2026-09-22 |
| CTT PHARMACEUTICAL H | P-Purchase | 10,900 | $0.05 | 2026-09-16 |
| CTT PHARMACEUTICAL H | P-Purchase | 3,500 | $0.05 | 2026-09-10 |